Dana-Farber Cancer Institute ( Site 3013)
Boston, Massachusetts 02215
1 studies enrolling now · 1 studies all time
What they study most
Malignant Neoplasm
Studies at this site
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
— Recruiting now